The White House planted a few new flags on drug pricing—and a lot of familiar ones—when it rolled out its 2020 budget proposal Monday afternoon.
The Trump proposal is just a jumping-off point for budget negotiations with—and within—Congress. But like the administration's drug-pricing blueprint released last year, it outlines presidential priorities for putting the squeeze on drug prices, namely increasing competition, encouraging "better negotiation" and lowering out-of-pocket costs for patients.
